Correlation Between Coya Therapeutics, and Quest PharmaTech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Coya Therapeutics, and Quest PharmaTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Coya Therapeutics, and Quest PharmaTech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Coya Therapeutics, Common and Quest PharmaTech, you can compare the effects of market volatilities on Coya Therapeutics, and Quest PharmaTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Coya Therapeutics, with a short position of Quest PharmaTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Coya Therapeutics, and Quest PharmaTech.

Diversification Opportunities for Coya Therapeutics, and Quest PharmaTech

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Coya and Quest is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Coya Therapeutics, Common and Quest PharmaTech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quest PharmaTech and Coya Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Coya Therapeutics, Common are associated (or correlated) with Quest PharmaTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quest PharmaTech has no effect on the direction of Coya Therapeutics, i.e., Coya Therapeutics, and Quest PharmaTech go up and down completely randomly.

Pair Corralation between Coya Therapeutics, and Quest PharmaTech

Given the investment horizon of 90 days Coya Therapeutics, Common is expected to generate 1.3 times more return on investment than Quest PharmaTech. However, Coya Therapeutics, is 1.3 times more volatile than Quest PharmaTech. It trades about 0.03 of its potential returns per unit of risk. Quest PharmaTech is currently generating about -0.07 per unit of risk. If you would invest  457.00  in Coya Therapeutics, Common on September 14, 2024 and sell it today you would earn a total of  117.00  from holding Coya Therapeutics, Common or generate 25.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy99.6%
ValuesDaily Returns

Coya Therapeutics, Common  vs.  Quest PharmaTech

 Performance 
       Timeline  
Coya Therapeutics, Common 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Coya Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Coya Therapeutics, is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Quest PharmaTech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Quest PharmaTech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, Quest PharmaTech is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Coya Therapeutics, and Quest PharmaTech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Coya Therapeutics, and Quest PharmaTech

The main advantage of trading using opposite Coya Therapeutics, and Quest PharmaTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Coya Therapeutics, position performs unexpectedly, Quest PharmaTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quest PharmaTech will offset losses from the drop in Quest PharmaTech's long position.
The idea behind Coya Therapeutics, Common and Quest PharmaTech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Commodity Directory
Find actively traded commodities issued by global exchanges